Chembio Diagn (CEMI) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts CEMI Hot Sheet
Price: $0.46 --0%
Financial Fact:
License and royalty revenue: 77.75K
Today's EPS Names:
SICP, OMID, ELME, More
Financial Fact:
License and royalty revenue: 77.75K
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
Chembio Diagn (NASDAQ: CEMI) reported Q1 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $5.2 million.
For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can JetBlue still avoid bankruptcy? Analysis says yes, but it won’t be easy
- Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
- BTIG reiterates neutral rating on Hershey ahead of Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
